This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n14http://linked.opendata.cz/ontology/domain/vavai/riv/typAkce/
dctermshttp://purl.org/dc/terms/
n20http://localhost/temp/predkladatel/
n10http://purl.org/net/nknouf/ns/bibtex#
n13http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n7http://linked.opendata.cz/resource/domain/vavai/projekt/
n19http://linked.opendata.cz/ontology/domain/vavai/
n15https://schema.org/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11120%2F01%3A00110153%21RIV%2F2002%2FMZ0%2F111202%2FN/
n21http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n11http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11120%2F01%3A00110153%21RIV%2F2002%2FMZ0%2F111202%2FN
rdf:type
skos:Concept n19:Vysledek
dcterms:description
Results of a study on combined drug treatment of NSCLS Results of a study on combined drug treatment of NSCLS
dcterms:title
Gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with NSCLC stage IIIB and IVAn interim analysis Gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with NSCLC stage IIIB and IVAn interim analysis
skos:prefLabel
Gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with NSCLC stage IIIB and IVAn interim analysis Gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with NSCLC stage IIIB and IVAn interim analysis
skos:notation
RIV/00216208:11120/01:00110153!RIV/2002/MZ0/111202/N
n3:strany
141;144
n3:aktivita
n21:P
n3:aktivity
P(NJ6732)
n3:dodaniDat
n11:2002
n3:domaciTvurceVysledku
n13:7693028
n3:druhVysledku
n16:D
n3:duvernostUdaju
n5:S
n3:entitaPredkladatele
n8:predkladatel
n3:idSjednocenehoVysledku
680981
n3:idVysledku
RIV/00216208:11120/01:00110153
n3:jazykVysledku
n17:eng
n3:klicovaSlova
Gemcitabine;cisplatin;versus;gemcitabine;carboplatin;patients;NSCLC;stage;interim;analysis
n3:klicoveSlovo
n4:patients n4:cisplatin n4:analysis n4:gemcitabine n4:NSCLC n4:carboplatin n4:interim n4:versus n4:Gemcitabine n4:stage
n3:kontrolniKodProRIV
[AEE1CA2BB03E]
n3:mistoKonaniAkce
Bologna
n3:mistoVydani
Bologna
n3:nazevZdroje
Lung Cancer Current Topics
n3:obor
n18:FC
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
3
n3:pocetUcastnikuAkce
0
n3:pocetZahranicnichUcastnikuAkce
0
n3:projekt
n7:NJ6732
n3:rokUplatneniVysledku
n11:2001
n3:tvurceVysledku
Zatloukal, Petr
n3:typAkce
n14:EUR
n3:zahajeniAkce
2001-01-01+01:00
s:numberOfPages
4
n10:hasPublisher
Monduzzi Ed.
n15:isbn
88-323-1603-X
n20:organizacniJednotka
11120